Bone and Parathyroid Strategies for Endocrinologists-Disease State Network Year-in-Review-Bone

Video Transcription

Video Summary

In this video content summary, Dr. Jad Sfeir and Dr. Rob Wormers review the latest findings in bone, metabolic bone diseases, and parathyroid disorders. They discuss important studies and advancements in the management and treatment of osteoporosis, vitamin D deficiencies, and rare bone disorders. They highlight the use of oral PTH for hypoparathyroidism and the potential benefits of trans-con PTH. They also address the use of denosumab in the treatment of osteoporosis, noting that longer duration of denosumab may lead to rebound bone loss after discontinuation. Additionally, they discuss the impact of parathyroidectomy on fracture risk and kidney stones, as well as the role of intraoperative PTH monitoring. The doctors also explore rare metabolic bone diseases such as acquired PTH resistance, autosomal dominant hypocalcemia type 1, and chronic non-bacterial osteomyelitis. They conclude by emphasizing the need for more research and precision medicine approaches in the field.

Keywords

bone

metabolic bone diseases

parathyroid disorders

osteoporosis

vitamin D deficiencies

rare bone disorders

oral PTH

denosumab

parathyroidectomy

precision medicine